Wesbanco Bank Inc Incyte Corp Transaction History

Wesbanco Bank Inc

  • $2.89 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 11, 2023
SELL
$57.77 - $65.93 $69,324 - $79,116
-1,200 Reduced 17.14%
5,800 $335,000
Q4 2022

Jan 18, 2023
BUY
$67.18 - $84.11 $470,260 - $588,770
7,000 New
7,000 $562,000
Q1 2022

Apr 25, 2022
BUY
$66.02 - $79.71 $1.19 Million - $1.43 Million
18,000 New
18,000 $1.43 Million

Others Institutions Holding INCY

# of Institutions
644
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Wesbanco Bank Inc Portfolio

Follow Wesbanco Bank Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email